Research-stage investigational psilocybin pharmacology and cannabinoid hybrid scaffold exploring multi-pathway recovery biology in the context of prolonged neurological dysregulation. Intended to support study of circuit-state endpoints including plasticity markers, neuroimmune readouts, and stress/reward pathway biomarkers.
Research-stage investigational cannabinoid-inspired scaffold intended to explore an expanded chemical design space beyond legacy cannabinoid architectures. Built around a differentiated dibenzo[a,e]pyran (xanthene) motif intended to support receptor profiling, selectivity studies, and exploratory work in neuroimmune and oxidative-stress-related biology.
Research-stage investigational platform drawing structural and biological inspiration from psilocybin pharmacology and fungal metabolite chemistry, including hericenone-related biology. Intended to explore neuroresilience-related pathways through measurable endpoints, with focus on neurotrophic signaling, oxidative-stress response, and neuroimmune tone.
